Stage III Ovarian Epithelial Cancer Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00085358Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)Treatment
NCT00079430Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerTreatment
NCT00002913Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerTreatment
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment
NCT00408655Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsTreatment